Zobrazeno 1 - 5
of 5
pro vyhledávání: '"TD Den Toom"'
Autor:
W. Dinjens, Titia G. Meijer, Nicole S. Verkaik, D C van Gent, C.H.M. van Deurzen, TD Den Toom, Agnes Jager, H.J. Dubbink, Roland Kanaar
Publikováno v:
Cancer Research. 79:P1-06
Introduction Better predictive biomarkers for response to Poly ADP-Ribose inhibitors (PARPi) are required, since on the one hand evidence is emerging that PARPi are also effective beyond germline BRCA mutated (gBRCAm) cancers and on the other hand gB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d85843c27e4e4e97b67731d632f84294
https://doi.org/10.1158/1538-7445.sabcs18-p1-06-06
https://doi.org/10.1158/1538-7445.sabcs18-p1-06-06
Autor:
Hermans BCM; Department of Pulmonary Diseases, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands., Derks JL; Department of Pulmonary Diseases, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands., Hillen LM; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van der Baan I; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van den Broek EC; PALGA Foundation, Houten, The Netherlands., von der Thüsen JH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Suylen RJ; Pathology-DNA, Location Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Atmodimedjo PN; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., den Toom TD; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Coumans-Stallinga C; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Timens W; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Speel EM; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Dingemans AC; Department of Pulmonary Diseases, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW-School for Oncology & Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Pulmonology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Mar 01; Vol. 150 (5), pp. 802-815. Date of Electronic Publication: 2021 Nov 10.
Autor:
Meijer TG; Erasmus MC-University Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Verkaik NS; Erasmus MC-University Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Deurzen CHM; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dubbink HJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., den Toom TD; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Sleddens HFBM; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., De Hoop EO; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dinjens WNM; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kanaar R; Erasmus MC-University Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Gent DC; Erasmus MC-University Medical Center, Rotterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Jager A; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2019 Dec; Vol. 3, pp. 1-12.
Autor:
Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, den Bakker MA, Sleddens HFBM, Dubbink HJ, den Toom TD, Dinjens WNM, Lips E, Nederlof PM, Smid M, van de Werken HJG, Kanaar R, Martens JWM, Jager A, van Gent DC
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 May 01; Vol. 25 (9), pp. 2935.
Autor:
Meijer TG; Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., Verkaik NS; Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., van Riet J; Erasmus MC University Medical Center Rotterdam, Cancer Computational Biology Center, Rotterdam, the Netherlands.; Department of Urology, Erasmus MC University Medical Center Rotterdam, the Netherlands., Naipal KAT; Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC University Medical Center Rotterdam, the Netherlands., den Bakker MA; Maasstad ziekenhuis, Rotterdam, the Netherlands., Sleddens HFBM; Department of Pathology, Erasmus MC University Medical Center Rotterdam, the Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC University Medical Center Rotterdam, the Netherlands., den Toom TD; Department of Pathology, Erasmus MC University Medical Center Rotterdam, the Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC University Medical Center Rotterdam, the Netherlands., Lips E; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof PM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., van de Werken HJG; Erasmus MC University Medical Center Rotterdam, Cancer Computational Biology Center, Rotterdam, the Netherlands.; Department of Urology, Erasmus MC University Medical Center Rotterdam, the Netherlands., Kanaar R; Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands., van Gent DC; Department of Molecular Genetics and Oncode Institute, Erasmus MC University Medical Center Rotterdam, the Netherlands. d.vangent@erasmusmc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 15; Vol. 24 (24), pp. 6277-6287. Date of Electronic Publication: 2018 Aug 23.